Africa News Guide: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Guide.

Press releases published on September 30, 2026

Sep. 30, 2026

Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion

Indeterminate GlobeNewswire

Sep. 30, 2026

AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video

Indeterminate GlobeNewswire

Sep. 30, 2026

Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards

Indeterminate GlobeNewswire

Sep. 30, 2026

AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450

Indeterminate GlobeNewswire

Sep. 30, 2026

American Lithium Minerals, Inc. Announces Completion of PCAOB Audit and Planned Uplisting to OTCQB in Fourth Quarter 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

R1 Therapeutics expands Series A to $80.5 million to advance global Phase 2b program in hyperphosphatemia

Indeterminate GlobeNewswire

Sep. 30, 2026

EVerZom successfully completes CTA-enabling preclinical studies of EVerGel™ required to support a clinical trial application

Indeterminate GlobeNewswire

Sep. 30, 2026

More Than 1,600 Participants Anchor Calroy Health Sciences' Joint Formulation Research

Indeterminate GlobeNewswire

Sep. 30, 2026

Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection

Indeterminate GlobeNewswire

Sep. 30, 2026

MEXC Invited to ISCR 2026 in South Korea, Joining Forces with Global Law Enforcement to Strengthen Cybercrime Defenses

Indeterminate GlobeNewswire

Sep. 30, 2026

Italfarmaco Presents New Givinostat (Duvyzat®) Clinical Data Supporting Preservation of Upper Limb Function in Duchenne Muscular Dystrophy Patients at the 2026 World Muscle Society Congress

Indeterminate GlobeNewswire

Sep. 30, 2026

Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering

Indeterminate GlobeNewswire

Sep. 30, 2026

Navigator Medicines Presents New Data at EADV 2026 as Bispecific Antibody Program Advances at Speed in Hidradenitis Suppurativa

Indeterminate GlobeNewswire

Sep. 30, 2026

GoldHaven Announces Fully Subscribed $1.0 Million Flow-Through Financing

Indeterminate GlobeNewswire